Patent details

EP2619226 Title: CARRIER IMMUNOGLOBULINS AND USES THEREOF

Basic Information

Publication number:
EP2619226
PCT Application Number:
US2011052841
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117638270
PCT Publication Number:
WO2012040518
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CARRIER IMMUNOGLOBULINS AND USES THEREOF
French Title of Invention:
IMMUNOGLOBULINES PORTEUSES ET LEUR UTILISATION
German Title of Invention:
TRÄGER-IMMUNGLOBULINE UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
22/09/2011
Grant date:
12/09/2018
EP Publication Date:
31/07/2013
PCT Publication Date:
29/03/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/09/2018
EP B1 Publication Date:
12/09/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/09/2018
Expiration date:
22/09/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/09/2018
 
 

Name:
Amgen Inc.
Address:
Patent Operations M/S 28-2-C One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Inventor

1

Name:
ARORA, Taruna
Address:
United States (US)

2

Name:
WALKER, Kenneth W.
Address:
United States (US)

3

Name:
JACOBSEN, Frederick W.
Address:
United States (US)

Priority

Priority Number:
385460 P
Priority Date:
22/09/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; C07K 16/00; C07K 16/18; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
201837
Publication date:
12/09/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/01/2019 Outgoing Correspondence 1